By Staff
Publix Super Markets announced its third-quarter 2026 financial results, reporting a decrease in both net earnings and its internal stock valuation:
Stock Price Valuation
- New Stock Price: $18.70 per share (down from $19.60 per share, effective Nov. 1, 2026).
- Trading Note: Publix stock is privately held and available for purchase exclusively by current eligible Publix associates and board members.
Key Q3 2026 Financial Highlights (Quarter Ended Sept. 26, 2026)
- Total Sales: $15.5 billion, a 1% increase compared to $15.4 billion in Q3 2025.
- Comparable-Store Sales: Decreased 0.6% year-over-year.
- Net Earnings: $1.07 billion, down 9.9% from $1.18 billion in Q3 2025.
- Earnings Per Share (EPS): $0.33 per share, down from $0.37 per share in Q3 2025.
- Adjusted Net Earnings (excluding unrealized gains on equity securities): $908 million, down 7.3% from $980 million in Q3 2025 ($0.29 EPS vs. $0.30 EPS).
Nine-Month Year-to-Date Performance
- Total YTD Sales: $47.4 billion, up 1.4% from $46.8 billion in 2025.
- YTD Comparable-Store Sales: Down 0.4%.
- YTD Net Earnings: $3.5 billion, down 1.5% from $3.6 billion in 2025.
Key Factors Behind the Results
- Medicare Maximum Fair Price (MFP) Impact: Federal drug price caps under the Inflation Reduction Act reduced prescription drug pricing, lowering pharmacy revenue.
- Consumer Spending Shifts: Tightened shopper budgets and economic pressures led to smaller basket sizes and slower sales momentum across stores.
(Visited 4 times, 9 visits today)